- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03150641
Delayed Cord Clamping at Term Cesarean
May 20, 2019 updated by: Columbia University
Maternal Blood Loss With Delayed Cord Clamping During Cesarean Delivery at Term
The purpose of this research study is to find out how delaying cutting the umbilical cord until one minute after delivery of the baby during a cesarean impacts the amount of blood the mother loses during surgery.
The study will also examine the benefits to the newborn from delayed cord clamping during cesarean.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
After delivery of a baby, the umbilical cord is cut to separate the baby from the placenta and the mother.
The best time to cut the umbilical cord of full term babies is unknown.
Traditionally, the umbilical cord is cut immediately at birth.
There is however, continued blood flow from the placenta to the baby after delivery and so there may be a benefit to the baby from waiting to cut the cord until one minute after delivery.
Studies show that delaying cutting the cord until at least one minute after delivery increases a full term baby's blood count in first two days of life and increases the baby's iron levels.
The impact of delaying cutting the umbilical cord on a mother's health is not fully known.
Delaying cutting the cord has minimal impact on the mother's health when the baby is delivered vaginally, but it is not known how delaying cutting the cord impacts the mother's health (and specifically the amount of blood a mother loses at delivery) when the baby is delivered by cesarean.
Study Type
Interventional
Enrollment (Actual)
113
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10032
- Columbia University Irving Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Singleton gestation
- Scheduled cesarean delivery at term (>=37 weeks)
Exclusion Criteria:
- Placenta previa
- Placenta abruption
- Intrauterine growth restriction with abnormal Dopplers
- Fetal anomalies
- Known fetal anemia
- Planned cord blood banking
- Preeclampsia
- Significant maternal anemia (Hgb <=7)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Immediate cord clamping
Umbilical cord clamped within 15 seconds of delivery of baby
|
The umbilical cord will be clamped and cut after delivery, with timing as specified in each arm
|
EXPERIMENTAL: Delayed cord clamping
Umbilical cord clamped 60 seconds after delivery of baby
|
The umbilical cord will be clamped and cut after delivery, with timing as specified in each arm
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maternal change in hemoglobin on post-operative day #1
Time Frame: Baseline to postoperative day #1 (range 1-4 days)
|
Difference in hemoglobin between routine pre-op CBC and a postpartum CBC collected on postoperative day #1, by venipuncture
|
Baseline to postoperative day #1 (range 1-4 days)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postpartum hemorrhage
Time Frame: From day of surgery to postpartum discharge (average 3-4 days)
|
Incidence of postpartum hemorrhage, defined as EBL >1000cc
|
From day of surgery to postpartum discharge (average 3-4 days)
|
Estimated blood loss
Time Frame: Day of surgery
|
Estimated blood loss at cesarean delivery, based on estimation provider team
|
Day of surgery
|
Need for Need for additional uterotonics
Time Frame: Day of surgery
|
Administration of uterotonics (beyond standard pitocin) during cesarean
|
Day of surgery
|
Maternal blood transfusion
Time Frame: From day of surgery to postpartum discharge (average 3-4 days)
|
Transfusion of blood products during or after delivery
|
From day of surgery to postpartum discharge (average 3-4 days)
|
Venous cord blood Hgb/Hct
Time Frame: Day of delivery
|
Obtained from cord blood sample
|
Day of delivery
|
Neonatal Hgb/Hct
Time Frame: Day 0-2 of life
|
Obtained from neonatal heel stick
|
Day 0-2 of life
|
APGAR scores
Time Frame: Day of delivery
|
Assigned at delivery
|
Day of delivery
|
Need for phototherapy for jaundice
Time Frame: From birth to hospital discharge (average 3-4 days)
|
Any use of phototherapy
|
From birth to hospital discharge (average 3-4 days)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Cynthia Gyamfi-Bannerman, MD, Columbia University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 18, 2017
Primary Completion (ACTUAL)
March 30, 2018
Study Completion (ACTUAL)
March 31, 2018
Study Registration Dates
First Submitted
May 9, 2017
First Submitted That Met QC Criteria
May 10, 2017
First Posted (ACTUAL)
May 12, 2017
Study Record Updates
Last Update Posted (ACTUAL)
May 22, 2019
Last Update Submitted That Met QC Criteria
May 20, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AAAR2937
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cesarean Delivery
-
Charite University, Berlin, GermanyCompletedCesarean Section Complications | Cesarean Delivery Affecting Newborn | Cesarean Delivery Affecting FetusGermany
-
Rambam Health Care CampusRecruitingCesarean Delivery Affecting Fetus | Delivery ComplicationIsrael
-
Assiut UniversityMinistry of Health, KuwaitNot yet recruiting
-
University of CalgaryCompleted
-
Assiut UniversityUnknown
-
Pujic BorislavaUnknownCesarean DeliverySerbia
-
Columbia UniversityCompletedCesarean DeliveryUnited States
-
S. Anna HospitalUnknownCesarean DeliveryItaly
-
University of British ColumbiaCompletedCesarean DeliveryCanada
-
Stanford UniversityCompleted
Clinical Trials on Umbilical cord clamping
-
Fondazione Poliambulanza Istituto OspedalieroCompleted
-
Acibadem UniversityCompletedCesarean Delivery | Delayed Separation of Umbilical CordTurkey
-
University of Rhode IslandBrown University; Women and Infants Hospital of Rhode IslandCompleted
-
Policlinico Abano TermeActive, not recruitingAcidosis | Hematocrit AnemiaItaly
-
Ankara UniversityUnknownPlacental Transfusion | Stem Cells
-
Xinhua Hospital, Shanghai Jiao Tong University...Shanghai First Maternity and Infant Hospital; Yangpu District Central Hospital...Completed
-
Mount Sinai Hospital, CanadaUnknown
-
University of Rhode IslandNational Institute of Nursing Research (NINR); Brown University; Women and Infants...CompletedSepsis | Intraventricular HemorrhageUnited States
-
Helse Møre og Romsdal HFNorwegian University of Science and TechnologyRecruitingInfant Conditions | Cesarean SectionNorway
-
Hainan Medical CollegeUnknown